Logo image of OB

OUTBRAIN INC (OB) Stock Fundamental Analysis

USA - NASDAQ:OB - US69002R1032 - Common Stock

2.74 USD
-0.07 (-2.49%)
Last: 6/9/2025, 8:00:02 PM
2.8 USD
+0.06 (+2.19%)
After Hours: 6/9/2025, 8:00:02 PM
Fundamental Rating

3

OB gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 69 industry peers in the Interactive Media & Services industry. OB has a bad profitability rating. Also its financial health evaluation is rather negative. OB has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year OB has reported negative net income.
OB had a positive operating cash flow in the past year.
In multiple years OB reported negative net income over the last 5 years.
OB had a positive operating cash flow in each of the past 5 years.
OB Yearly Net Income VS EBIT VS OCF VS FCFOB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M

1.2 Ratios

OB has a Return On Assets (-2.99%) which is in line with its industry peers.
OB has a Return On Equity (-10.64%) which is in line with its industry peers.
Industry RankSector Rank
ROA -2.99%
ROE -10.64%
ROIC N/A
ROA(3y)-0.58%
ROA(5y)0.02%
ROE(3y)-2.34%
ROE(5y)-0.13%
ROIC(3y)N/A
ROIC(5y)N/A
OB Yearly ROA, ROE, ROICOB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 -10 -20

1.3 Margins

Looking at the Gross Margin, with a value of 24.31%, OB is doing worse than 84.51% of the companies in the same industry.
OB's Gross Margin has been stable in the last couple of years.
OB does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 24.31%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.01%
GM growth 5Y0.91%
OB Yearly Profit, Operating, Gross MarginsOB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 5 10 15 20

3

2. Health

2.1 Basic Checks

OB does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for OB has been increased compared to 1 year ago.
OB has less shares outstanding than it did 5 years ago.
OB has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
OB Yearly Shares OutstandingOB Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
OB Yearly Total Debt VS Total AssetsOB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

OB has an Altman-Z score of 0.50. This is a bad value and indicates that OB is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.50, OB is in line with its industry, outperforming 42.25% of the companies in the same industry.
The Debt to FCF ratio of OB is 15.66, which is on the high side as it means it would take OB, 15.66 years of fcf income to pay off all of its debts.
OB has a Debt to FCF ratio (15.66) which is in line with its industry peers.
A Debt/Equity ratio of 1.32 is on the high side and indicates that OB has dependencies on debt financing.
The Debt to Equity ratio of OB (1.32) is worse than 80.28% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.32
Debt/FCF 15.66
Altman-Z 0.5
ROIC/WACCN/A
WACC8.68%
OB Yearly LT Debt VS Equity VS FCFOB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M 250M

2.3 Liquidity

OB has a Current Ratio of 1.13. This is a normal value and indicates that OB is financially healthy and should not expect problems in meeting its short term obligations.
OB's Current ratio of 1.13 is on the low side compared to the rest of the industry. OB is outperformed by 76.06% of its industry peers.
A Quick Ratio of 1.13 indicates that OB should not have too much problems paying its short term obligations.
The Quick ratio of OB (1.13) is worse than 76.06% of its industry peers.
Industry RankSector Rank
Current Ratio 1.13
Quick Ratio 1.13
OB Yearly Current Assets VS Current LiabilitesOB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 200M 400M 600M

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 25.00% over the past year.
Looking at the last year, OB shows a small growth in Revenue. The Revenue has grown by 4.16% in the last year.
The Revenue has been growing slightly by 5.30% on average over the past years.
EPS 1Y (TTM)25%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-100%
Revenue 1Y (TTM)4.16%
Revenue growth 3Y-4.31%
Revenue growth 5Y5.3%
Sales Q2Q%31.98%

3.2 Future

Based on estimates for the next years, OB will show a very strong growth in Earnings Per Share. The EPS will grow by 101.45% on average per year.
Based on estimates for the next years, OB will show a small growth in Revenue. The Revenue will grow by 7.84% on average per year.
EPS Next Y977.64%
EPS Next 2Y355.64%
EPS Next 3Y101.45%
EPS Next 5YN/A
Revenue Next Year59.77%
Revenue Next 2Y29.71%
Revenue Next 3Y7.84%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
OB Yearly Revenue VS EstimatesOB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B
OB Yearly EPS VS EstimatesOB Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 0.2 -0.2 0.4 -0.4 0.6 0.8

6

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for OB. In the last year negative earnings were reported.
OB is valuated cheaply with a Price/Forward Earnings ratio of 3.30.
Compared to the rest of the industry, the Price/Forward Earnings ratio of OB indicates a rather cheap valuation: OB is cheaper than 100.00% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.70, OB is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 3.3
OB Price Earnings VS Forward Price EarningsOB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, OB is valued cheaply inside the industry as 94.37% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 6.45
EV/EBITDA N/A
OB Per share dataOB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10

4.3 Compensation for Growth

OB's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
OB's earnings are expected to grow with 101.45% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y355.64%
EPS Next 3Y101.45%

0

5. Dividend

5.1 Amount

No dividends for OB!.
Industry RankSector Rank
Dividend Yield N/A

OUTBRAIN INC

NASDAQ:OB (6/9/2025, 8:00:02 PM)

After market: 2.8 +0.06 (+2.19%)

2.74

-0.07 (-2.49%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryInteractive Media & Services
Earnings (Last)05-09 2025-05-09/bmo
Earnings (Next)08-06 2025-08-06
Inst OwnersN/A
Inst Owner Change0.31%
Ins OwnersN/A
Ins Owner Change1.56%
Market Cap258.38M
Analysts78.46
Price Target5.44 (98.54%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-60.21%
Min EPS beat(2)-102.79%
Max EPS beat(2)-17.62%
EPS beat(4)2
Avg EPS beat(4)50.06%
Min EPS beat(4)-102.79%
Max EPS beat(4)284.85%
EPS beat(8)5
Avg EPS beat(8)515.51%
EPS beat(12)7
Avg EPS beat(12)306.55%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-4.58%
Min Revenue beat(2)-8.54%
Max Revenue beat(2)-0.62%
Revenue beat(4)0
Avg Revenue beat(4)-5.74%
Min Revenue beat(4)-9.09%
Max Revenue beat(4)-0.62%
Revenue beat(8)0
Avg Revenue beat(8)-5.76%
Revenue beat(12)2
Avg Revenue beat(12)-3.42%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-10.42%
PT rev (3m)-35%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-180.1%
EPS NY rev (1m)0%
EPS NY rev (3m)-12.45%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.31%
Revenue NY rev (1m)-0.27%
Revenue NY rev (3m)28.17%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 3.3
P/S 0.27
P/FCF 6.45
P/OCF 4.38
P/B 0.54
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.06
EYN/A
EPS(NY)0.83
Fwd EY30.31%
FCF(TTM)0.42
FCFY15.5%
OCF(TTM)0.63
OCFY22.83%
SpS10.17
BVpS5.03
TBVpS-5.34
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.99%
ROE -10.64%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 24.31%
FCFM 4.17%
ROA(3y)-0.58%
ROA(5y)0.02%
ROE(3y)-2.34%
ROE(5y)-0.13%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.01%
GM growth 5Y0.91%
F-Score4
Asset Turnover0.57
Health
Industry RankSector Rank
Debt/Equity 1.32
Debt/FCF 15.66
Debt/EBITDA N/A
Cap/Depr 69.03%
Cap/Sales 1.98%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.13
Quick Ratio 1.13
Altman-Z 0.5
F-Score4
WACC8.68%
ROIC/WACCN/A
Cap/Depr(3y)94.29%
Cap/Depr(5y)88.52%
Cap/Sales(3y)2.24%
Cap/Sales(5y)2.01%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)25%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-100%
EPS Next Y977.64%
EPS Next 2Y355.64%
EPS Next 3Y101.45%
EPS Next 5YN/A
Revenue 1Y (TTM)4.16%
Revenue growth 3Y-4.31%
Revenue growth 5Y5.3%
Sales Q2Q%31.98%
Revenue Next Year59.77%
Revenue Next 2Y29.71%
Revenue Next 3Y7.84%
Revenue Next 5YN/A
EBIT growth 1Y-360.73%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year3702.14%
EBIT Next 3Y261.82%
EBIT Next 5YN/A
FCF growth 1Y199.3%
FCF growth 3Y11.78%
FCF growth 5Y51.85%
OCF growth 1Y520.46%
OCF growth 3Y6.5%
OCF growth 5Y32.58%